Ningmitai capsule in patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, prospective, randomized, parallel, positive-controlled study

Jingjing Gao(Chinese Academy of Sciences), Xiansheng Zhang(Anhui Medical University), Junhua Du(Anhui Medical University), Liang Zheng(Xi'an Medical University), Qunli Men(Baoji City Central Hospital), Wentao Yang(Jilin Agricultural University), Chang Yin Liang(Anhui Medical University), Dong Wang(Zhejiang Chinese Medical University), Wei Wang(First Hospital of China Medical University), Qiang Liu(Huazhong University of Science and Technology), Daoyuan Wang(People's Liberation Army No. 150 Hospital), Yi Cheng(Anhui University of Traditional Chinese Medicine), Lixin Wu(First Affiliated Hospital of Zhengzhou University), Xiaolei Jiang(Sichuan Mianyang 404 Hospital)
Frontiers in Pharmacology
December 3, 2025
10.3389/fphar.2025.1667819
Cited by 1

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition
|Nature Neuroscience|2020|185
Systemic clearance of <i>p16<sup>INK4a</sup></i>‐positive senescent cells mitigates age‐associated intervertebral disc degeneration
|Aging Cell|2019|170
Bone marrow hematopoiesis drives multiple sclerosis progression
|Cell|2022|166
β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice
|Redox Biology|2023|151